TOP TIERMARKET NEWSWIRE
News & sentiment

Pelthos Therapeutics (PTHS) — News & AI sentiment

Pelthos Therapeutics (PTHS) news roundup. 3 stories aggregated over the last 30 days. Average 30-day sentiment is 47.7/100. Recent insider activity (SEC Form 4, 90-day window): 1 purchases totalling $1000K and 4 sales totalling $64K — net buying of $936K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
3
avg sentiment 47.7/100
Insider net (90d)
$936K
1 buys · 4 sells
Congress (90d)
0
0 buys · 0 sells

PTHS news in the last 24 hours, 7 days, 30 days and 90 days

How much PTHS coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowPTHS storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days347.7/100PTHS headlines →
Last 90 days1552.7/100PTHS headlines →

Latest stories on PTHS

Pelthos (PTHS) Q2 2026 Earnings Call Transcript
The Motley Fool67 · bullishearnings
Aug 20
Aug 17
Aug 16
Aug 13
Aug 13
Aug 13
Aug 13
Aug 13
Aug 13
Aug 13
Aug 3
Jul 27
Jul 24
Jul 24
Jun 30
May 28
May 28
Open PTHS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →